An artificial uterus (or artificial womb) is a hypothetical device that would allow for extracorporeal pregnancy by growing a fetus outside the body of an organism that would normally carry the fetus to term.
An artificial uterus,
as a replacement organ, would have many applications. It could be used
to assist male or female couples in the development of a fetus. This can potentially be performed as a switch from a natural uterus to an artificial uterus, thereby moving the threshold of fetal viability to a much earlier stage of pregnancy. In this sense, it can be regarded as a neonatal incubator with very extended functions. It could also be used for the initiation of fetal development. An artificial uterus could also help make fetal surgery procedures at an early stage an option instead of having to postpone them until term of pregnancy.
In 2016 scientists published two studies regarding human embryos
developing for thirteen days within an ecto-uterine environment.
Currently, a 14-day rule prevents human embryos from being kept in
artificial wombs longer than 14 days. This rule has been codified into
law in twelve countries.
In 2017 fetal researchers at the Children's Hospital of Philadelphia published a study showing they had grown premature lamb fetuses for four weeks in an extra-uterine life support system.
Components
An artificial uterus, sometimes referred to as an 'exowomb',
would have to provide nutrients and oxygen to nurture a foetus, as well
as dispose of waste material. The scope of an artificial uterus (or
"artificial uterus system" to emphasize a broader scope) may also
include the interface serving the function otherwise provided by the placenta, an amniotic tank functioning as the amniotic sac, as well as an umbilical cord.
Nutrition, oxygen supply and waste disposal
A woman may still supply nutrients and dispose of waste products if the artificial uterus is connected to her. She may also provide immune protection against diseases by passing of IgG antibodies to the embryo or fetus.
Artificial supply and disposal have the potential
advantage of allowing the fetus to develop in an environment that is not
influenced by the presence of disease, environmental pollutants,
alcohol, or drugs which a human may have in the circulatory system. There is no risk of an immune reaction towards the embryo or fetus that could otherwise arise from insufficient gestational immune tolerance. Some individual functions of an artificial supplier and disposer include:
- Waste disposal may be performed through dialysis.
- For oxygenation of the embryo or fetus, and removal of carbon dioxide, extracorporeal membrane oxygenation (ECMO) is a functioning technique, having successfully kept goat fetuses alive for up to 237 hours in amniotic tanks. ECMO is currently a technique used in selected neonatal intensive care units to treat term infants with selected medical problems that result in the infant's inability to survive through gas exchange using the lungs. However, the cerebral vasculature and germinal matrix are poorly developed in fetuses, and subsequently, there is an unacceptably high risk for intraventricular hemorrhage (IVH) if administering ECMO at a gestational age less than 32 weeks. Liquid ventilation has been suggested as an alternative method of oxygenation, or at least providing an intermediate stage between the womb and breathing in open air.
- For artificial nutrition, current techniques are problematic. Total parenteral nutrition, as studied on infants with severe short bowel syndrome, has a 5-year survival of approximately 20%.
- Issues related to hormonal stability also remain to be addressed.
Theoretically, animal suppliers and disposers may be used, but when involving an animal's uterus the technique may rather be in the scope of interspecific pregnancy.
Uterine wall
In a normal uterus, the myometrium of the uterine wall functions to expel the fetus at the end of a pregnancy, and the endometrium
plays a role in forming the placenta. An artificial uterus may include
components of equivalent function. Methods have been considered to
connect an artificial placenta and other "inner" components directly to
an external circulation.
Interface (artificial placenta)
An interface between the supplier and the embryo or fetus may be entirely artificial, e.g. by using one or more semipermeable membranes such as is used in extracorporeal membrane oxygenation (ECMO).
There is also potential to grow a placenta using human endometrial cells.
In 2002, it was announced that tissue samples from cultured endometrial
cells removed from a human donor had successfully grown.
The tissue sample was then engineered to form the shape of a natural
uterus, and human embryos were then implanted into the tissue. The
embryos correctly implanted into the artificial uterus' lining and
started to grow. However, the experiments were halted after six days to
stay within the permitted legal limits of in vitro fertilisation (IVF) legislation in the United States.
A human placenta may theoretically be transplanted inside an
artificial uterus, but the passage of nutrients across this artificial
uterus remains an unsolved issue.
Amniotic tank (artificial amniotic sac)
The main function of an amniotic tank would be to fill the function of the amniotic sac
in physically protecting the embryo or fetus, optimally allowing it to
move freely. It should also be able to maintain an optimal temperature. Lactated Ringer's solution can be used as a substitute for amniotic fluid.
Umbilical cord
Theoretically, in case of premature removal of the fetus from the natural uterus, the natural umbilical cord could be used, kept open either by medical inhibition of physiological occlusion, by anti-coagulation as well as by stenting or creating a bypass for sustaining blood flow between the mother and fetus.
Research and development
Emanuel M. Greenberg
Emanuel M. Greenberg wrote various papers on the topic of the artificial womb and its potential use in the future.
On July 22, 1954 Emanuel M. Greenberg filed a patent on the design for an artificial womb.
The patent included two images of the design for an artificial womb.
The design itself included a tank to place the fetus filled with
amniotic fluid, a machine connecting to the umbilical cord, blood pumps,
an artificial kidney, and a water heater. He was granted the patent on
November 15, 1955.
On May 11, 1960, Greenberg wrote to the editors of the American
Journal of Obstetrics and Gynecology. Greenberg claimed that the journal
had published the article "Attempts to Make an 'Artificial Uterus'",
which failed to include any citations on the topic of the artificial
uterus.
According to Greenberg, this suggested that the idea of the artificial
uterus was a new one although he himself had published several papers on
the topic.
Juntendo University in Tokyo
In 1996, Juntendo University in Tokyo developed the extra-uterine fetal incubation (EUFI).
The project was led by Yoshinori Kuwabara, who was interested in the
development of immature newborns. The system was developed using
fourteen goat fetuses that were then placed into artificial amniotic
fluid under the same conditions of a mother goat. Kuwabara and his team succeeded in keeping the goat fetuses in the system for three weeks. The system however, ran into several problems and was not ready for human testing. Kuwabara remained hopeful that the system would be improved and would later be used on human fetuses.
Children's Hospital of Philadelphia
In
2017, researchers at the Children's Hospital of Philadelphia were able
to further develop the extra-uterine system. The study uses fetal lambs
which are then placed in a plastic bag filled with artificial amniotic
fluid.
The umbilical cord of the lambs are attached to a machine outside of
the bag designed to act like a placenta and provide oxygen and nutrients
and also remove any waste.
The researchers kept the machine "in a dark, warm room where
researchers can play the sounds of the mother's heart for the lamb
fetus." The system succeeded in helping the premature lamb fetuses develop normally for a month.
Alan Flake, a fetal surgeon at the Children's Hospital of Philadelphia
hopes to move testing to premature human fetuses, but this could take
anywhere from three to five years to become a reality.
Flake, who led the study does not believe the new technology could ever
be used to recreate a full pregnancy and does not personally intend to
create the technology to do so.
Philosophical considerations
Bioethics
The development of artificial uteri and ectogenesis raises bioethical and legal considerations, and also has important implications for reproductive rights and the abortion debate.
Artificial uteri may expand the range of fetal viability, raising questions about the role that fetal viability plays within abortion law.
Within severance theory, for example, abortion rights only include the
right to remove the fetus, and do not always extend to the termination
of the fetus. If transferring the fetus from a woman's womb to an
artificial uterus is possible, the choice to terminate a pregnancy in
this way could provide an alternative to aborting the fetus.
There are also theoretical concerns that children who develop in
an artificial uterus may lack "some essential bond with their mothers
that other children have".
Gender equality and LGBT
In the 1970 book The Dialectic of Sex, feminist Shulamith Firestone wrote that differences in biological reproductive roles are a source of gender inequality.
Firestone singled out pregnancy and childbirth, making the argument
that an artificial womb would free "women from the tyranny of their
reproductive biology."
Arathi Prasad argues in her column on The Guardian
in her article "How artificial wombs will change our ideas of gender,
family and equality" that "It will [...] give men an essential tool to
have a child entirely without a woman, should they choose. It will ask
us to question concepts of gender and parenthood." She furthermore
argues for the benefits for same-sex couples: "It might also mean that
the divide between mother and father can be dispensed with: a womb
outside a woman’s body would serve women, trans women and male same-sex
couples equally without prejudice."